Accumulated Other Comprehensive Income (Loss), Net of Tax of ARTELO BIOSCIENCES, INC. from 31 Aug 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Summary
ARTELO BIOSCIENCES, INC. quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax in USD history and change rate from 31 Aug 2017 to 31 Dec 2025.
  • ARTELO BIOSCIENCES, INC. Accumulated Other Comprehensive Income (Loss), Net of Tax for the quarter ending 31 Dec 2025 was $272,000, a 35% decline year-over-year.
Source SEC data
View on sec.gov
Accumulated Other Comprehensive Income (Loss), Net of Tax, Quarterly (USD)
Accumulated Other Comprehensive Income (Loss), Net of Tax, YoY Quarterly Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $272,000 -$70,000 -35% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $277,000 -$59,000 -27% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $295,000 -$92,000 -45% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $227,000 -$24,000 -12% 31 Mar 2025 8-K 11 Jul 2025
Q4 2024 $202,000 +$1,000 +0.49% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $218,000 -$19,000 -9.5% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $203,000 -$2,000 -1% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $203,000 +$2,000 +0.98% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $203,000 +$51,000 +20% 31 Dec 2023 8-K 11 Jul 2025
Q3 2023 $199,000 +$189,000 +49% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $201,000 -$25,000 -14% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $205,000 -$141,000 -220% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $254,000 -$236,000 -1311% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $388,000 -$406,000 -2256% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $176,000 -$225,383 -456% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $64,000 -$111,900 -234% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $18,000 -$65,527 -138% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $18,000 -$46,000 -72% 31 Aug 2021 10-K 31 Mar 2023 2022 FY
Q2 2021 $49,383 -$1,121 -2.2% 31 May 2021 10-Q 12 Jul 2021 2021 Q3
Q1 2021 $47,900 +$31,943 +200% 28 Feb 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 $47,527 +$40,989 +627% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 $64,000 +$73,806 31 Aug 2020 10-KT 21 Mar 2022 2022 Q1
Q2 2020 $50,504 +$60,731 31 May 2020 10-Q 13 Jul 2020 2020 Q3
Q1 2020 $15,957 +$26,955 29 Feb 2020 10-Q 13 Apr 2020 2020 Q2
Q4 2019 $6,538 +$13,930 30 Nov 2019 10-Q 14 Jan 2020 2020 Q1
Q3 2019 $9,806 +$2,474 +20% 31 Aug 2019 10-K 04 Nov 2020 2020 FY
Q2 2019 $10,227 +$1,457 +12% 31 May 2019 10-Q 15 Jul 2019 2019 Q3
Q1 2019 $10,998 -$9,376 -578% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 $7,392 -$7,024 -1909% 30 Nov 2018 10-Q 14 Jan 2019 2019 Q1
Q3 2018 $12,280 -$12,937 -1969% 31 Aug 2018 10-K/A 18 Dec 2019 2019 FY
Q2 2018 $11,684 31 May 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 $1,622 28 Feb 2018 10-Q/A 14 May 2018 2018 Q2
Q4 2017 $368 30 Nov 2017 10-Q/A 21 Mar 2018 2018 Q1
Q3 2017 $657 31 Aug 2017 10-K 29 Nov 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.